MONTEREY, Calif.--(BUSINESS WIRE)--Elevation Spine announced today that its Saber-C Anterior Cervical Fusion System has surpassed 5,000 implantations, a milestone that reflects growing surgeon adoption of its proprietary integrated-fixation approach to anterior cervical discectomy and fusion (ACDF). The Saber-C system combines the stability of traditional anterior cervical plating with the streamlined workflow of a zero-profile interbody construct through its proprietary Saber™ in-line spike fixation technology.
Elevation Spine Surpasses 5,000 Saber-C® Implantations, Marking a Significant Milestone for Its Integrated Cervical Fixation Platform
1 min read Premium comments
milestoneanterior cervical discectomy and fusionElevation SpineSaber-C Anterior Cervical Fusion Systemzero profile
“Five thousand implantations is more than a number. It’s five thousand data points from surgeons in the OR telling us what works, what they need, and where to go next. That feedback has shaped every iteration of this platform. It’s the foundation we build on, and it’s what gives us confidence that what we’re bringing to market is exactly what spine surgeons have been asking for.” — Charlie Gilbride, CEO, Elevation Spine
“I’ve used Saber-C across a range of cases and the consistency is what stands out. The spike fixation deploys predictably, the workflow is clean, and I’m not managing a separate plating step. Five thousand implantations speaks for itself, this system has earned its track record.”
— Tien Le, MD, Total Spine & Brain Institute
One of the few zero-profile ACDF systems cleared as an anterior cervical plate, Saber-C provides surgeons with a stronger foundation than standalone interbody classification alone. Its in-line spike fixation technology enables single-step simultaneous deployment at both endplates, reducing procedural complexity without compromising stability. The system supports both spike and screw fixation options and offers seven total points of fixation, a profile exclusive to the Saber-C platform.
As the platform crosses the 5,000-implantation threshold, Elevation Spine looks ahead to the next chapter of the Saber-C system, with a next-generation update anticipated for commercial launch later this year.
About Elevation Spine
Elevation Spine is a Monterey, CA-based developer of integrated-fixation spinal technologies. The Saber platform integrates fixation and interbody support across the cervical and lumbar spine.
Contacts
Media Contact: Martin Klazmer | martinklazmer@elevationspine.com
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
Elevation Spine's Saber-C Anterior Cervical Fusion System has surpassed 5,000 implantations, indicating strong surgeon adoption of its integrated-fixation ACDF platform. This milestone highlights the company's strategy to combine plating stability with zero-profile interbody efficiency, positioning it competitively. A next-generation update is anticipated, suggesting continued market innovation and expansion for Elevation Spine in the spine segment.
- The system's classification as an anterior cervical plate provides a stronger market position than standalone interbody devices.
- Growing adoption and a planned next-generation launch signal Elevation Spine's strategic focus on market leadership.
PhD Lens: Clinical and outcomes impact
The Saber-C Anterior Cervical Fusion System, utilizing proprietary Saber™ in-line spike fixation technology, has achieved 5,000 implantations. This system integrates the stability of traditional anterior cervical plating with a zero-profile interbody construct. Its design allows single-step, simultaneous spike deployment at both endplates, offering seven total points of fixation and supporting both spike and screw options, enhancing procedural efficiency and stability.
- The system is cleared as an anterior cervical plate, providing a robust fixation foundation.
- Its in-line spike fixation mechanism aims to reduce procedural complexity while maintaining stability.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.